Pruritus - Pipeline Review, H1 2019

Global Markets Direct’s, ‘Pruritus - Pipeline Review, H1 2019’, provides an overview of the Pruritus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Pruritus

- The report reviews pipeline therapeutics for Pruritus by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Pruritus therapeutics and enlists all their major and minor projects

- The report assesses Pruritus therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Pruritus

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Pruritus

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Pruritus pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Albireo Pharma Inc

Amgen Inc

AOBiome LLC

Asana BioSciences LLC

Cara Therapeutics Inc

Celgene Corp

Chugai Pharmaceutical Co Ltd

ELORAC Inc

GlaxoSmithKline Plc

Hanlim Pharm ...

Albireo Pharma Inc

Amgen Inc

AOBiome LLC

Asana BioSciences LLC

Cara Therapeutics Inc

Celgene Corp

Chugai Pharmaceutical Co Ltd

ELORAC Inc

GlaxoSmithKline Plc

Hanlim Pharm Co Ltd

Hydra Biosciences Inc

Jiangsu Hengrui Medicine Co Ltd

Menlo Therapeutics Inc

NeuroCycle Therapeutics GmbH

Patagonia Pharmaceuticals LLC

RDD Pharma Ltd

Roivant Sciences Ltd

Saniona AB

Sanwa Kagaku Kenkyusho Co Ltd

Sienna Biopharmaceuticals Inc

Sumitomo Dainippon Pharma Co Ltd

Teikoku Pharma USA Inc

Tioga Pharmaceuticals Inc

Toray Industries Inc

Vanda Pharmaceuticals Inc

Table of Contents

Table of Contents

Introduction

Pruritus – Overview

Pruritus – Therapeutics Development

Pruritus – Therapeutics Assessment

Pruritus – Companies Involved in Therapeutics Development

Pruritus – Drug Profiles

Pruritus – Dormant Projects

Pruritus ...

Table of Contents

Introduction

Pruritus – Overview

Pruritus – Therapeutics Development

Pruritus – Therapeutics Assessment

Pruritus – Companies Involved in Therapeutics Development

Pruritus – Drug Profiles

Pruritus – Dormant Projects

Pruritus – Discontinued Products

Pruritus – Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Pruritus, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under ...

List of Tables

Number of Products under Development for Pruritus, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Companies, H1 2019 (Contd..1), H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Products under Development by Companies, H1 2019

Products under Development by Companies, H1 2019 (Contd..1), H1 2019

Products under Development by Companies, H1 2019 (Contd..2), H1 2019

Products under Development by Universities/Institutes, H1 2019

Number of Products by Stage and Target, H1 2019

Number of Products by Stage and Mechanism of Action, H1 2019

Number of Products by Stage and Route of Administration, H1 2019

Number of Products by Stage and Molecule Type, H1 2019

Pruritus – Pipeline by Albireo Pharma Inc, H1 2019

Pruritus – Pipeline by Amgen Inc, H1 2019

Pruritus – Pipeline by AOBiome LLC, H1 2019

Pruritus – Pipeline by Asana BioSciences LLC, H1 2019

Pruritus – Pipeline by Cara Therapeutics Inc, H1 2019

Pruritus – Pipeline by Celgene Corp, H1 2019

Pruritus – Pipeline by Chugai Pharmaceutical Co Ltd, H1 2019

Pruritus – Pipeline by ELORAC Inc, H1 2019

Pruritus – Pipeline by GlaxoSmithKline Plc, H1 2019

Pruritus – Pipeline by Hanlim Pharm Co Ltd, H1 2019

Pruritus – Pipeline by Hydra Biosciences Inc, H1 2019

Pruritus – Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2019

Pruritus – Pipeline by Menlo Therapeutics Inc, H1 2019

Pruritus – Pipeline by NeuroCycle Therapeutics GmbH, H1 2019

Pruritus – Pipeline by Patagonia Pharmaceuticals LLC, H1 2019

Pruritus – Pipeline by RDD Pharma Ltd, H1 2019

Pruritus – Pipeline by Roivant Sciences Ltd, H1 2019

List of Figures

List of Figures

Number of Products under Development for Pruritus, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products by ...

List of Figures

Number of Products under Development for Pruritus, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products by Top 10 Targets, H1 2019

Number of Products by Stage and Top 10 Targets, H1 2019

Number of Products by Top 10 Mechanism of Actions, H1 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019

Number of Products by Routes of Administration, H1 2019

Number of Products by Stage and Routes of Administration, H1 2019

Number of Products by Molecule Types, H1 2019

Number of Products by Stage and Molecule Types, H1 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports